Introduction 42
Transcription activators play essential roles in gene regulation and regulation of activator 43 function is often the endpoint of many signaling pathways, serving to modulate transcription in 44 response to developmental pathways, growth, stress, and other environmental signals (1, 2). 45
The targeting of multiple activators in different combinations to gene regulatory regions leads 46 to diverse patterns of gene regulation. Activators can enhance RNA Polymerase II transcription 47 through binding to coactivator complexes such as Mediator, SAGA, TFIID, Swi/Snf and NuA4, 48 complexes that contact the basal transcription machinery and/or function to modify chromatin 49 (3, 4) . Most eukaryotic activators contain separate DNA binding and transcription activation 50 domains (ADs) (3, 5). Unlike DNA binding domains, which are usually structurally ordered, 51 eukaryotic ADs are intrinsically disordered, lacking a stable structure (6-10). 52 53 Many types of intrinsically disordered proteins bind their targets via short linear motifs, 3-10 54 residue sequences that function as recognition sites for enzymes such as kinases, acetylases or 55 sequence differences, Met4, Ino2, and Gcn4 have similar function in transcription activation 85 assays, require Med15 for activation of Mediator Tail dependent promoters, and both ADs bind 86
Med15 activator-binding domains with low micromolar affinities. These and other results 87 suggest that Gcn4, Met4 and Ino2 use a similar strategy to bind Mediator that involves a large, 88 dynamic and fuzzy protein interface. 89 90 Methods 91
Strains and Plasmids 92
All yeast strains and primary plasmids used in this work are listed in Table S1 . 93 94 Cell growth assays and measurement of steady state mRNA levels 95
Yeast strains were grown in duplicate to an OD 600 of 0.5-0.8 in 2% (wt/vol) dextrose synthetic 96 complete Ile-Val-Leu medium at 30 °C. Cells were induced with 0.5 μg/mL SM for 90 min to 97 induce amino acid starvation (27) , RNA was extracted and assayed in triplicate by quantitative PCR, and the results were analyzed as described (27) . 99 100
Quantitation of in Vivo AD-Gcn4 Levels 101
Cells (1.5 mL) from the cultures used for the above mRNA analysis were pelleted and incubated 102 in 0.1M NaOH for 5 minutes at room temp. Cells were then pelleted and resuspended in 1× 103 lithium dodecyl sulfate sample buffer (Life Technologies) containing 50 mM DTT and treated 104 and analyzed as previously described (18). 105 106 Protein purification. 107
All proteins were expressed in BL21 (DE3) RIL E. coli. Med15 constructs were expressed and 108 purified as described in Tuttle et al. (20) . Ino2 1-41-(GS) 3 -96-160 ((GS) 3 is the linker: GSGSGS) 109 and Met4 72-160 constructs were expressed as N-terminal His6-SUMO-tagged proteins 110 (Invitrogen). Cells were lysed in 50 mM HEPES pH 7.0, 500 mM NaCl, 40 mM Imidazole, 10% 111 glycerol, 1 mM PMSF, 5 mM DTT and purified using Ni-Sepharose High Performance resin (GE 112 Healthcare). Proteins were eluted in 50 mM HEPES pH 7.0, 500 mM NaCl, 500 mM Imidazole, 113 10% glycerol, 1 mM PMSF, 1 mM DTT. Purified SUMO-tagged proteins were concentrated using 114 10K MWCO centrifugal filters (Millipore), diluted 10x in 50 mM HEPES pH 7.0, 500 mM NaCl, 40 115 mM Imidazole, 10% glycerol, 1 mM PMSF, 5 mM DTT, and digested with SUMO protease for 3-5 116 hrs at room temperature using ~1:800 protease:protein ratio. Cleaved His6-Sumo tag was 117 removed using Ni-Sepharose. Peptides were further purified by chromatography on Source 15Q 118 (GE Healthcare) using a 50-350 mM NaCl gradient. To remove residual SUMO tag in the sample 119 due to co-elution on Source 15Q, Ino2 peptides were purified over SUMO-1(CR) resin 120 
Mediator tail-dependence of transcription activators 173
As a first step in exploring the mechanism of yeast ADs in comparison to Gcn4, we tested the 174 activity and coactivator dependence of several previously characterized transcription factors. than wild type Gcn4. The two Rtg3 ADs have different relative activity, depending on the 193 promoter, with the C-terminal AD having the most activity at HIS4. Western analysis showed 194 that all proteins were expressed and that the level of expression did not correlate with AD 195 function (Fig 2A) . Mediator tail module, a direct binding target for Gcn4. For example, ARG3 shows 5-10-fold 199 dependence on Med15, a Mediator Tail subunit, while HIS4 shows ~2-fold dependence (27). We 200 measured Mediator tail dependence of these chimeric activators by comparing expression in 201 WT vs Dmed15. As previously found with Gcn4, all chimeric ADs showed the strongest Med15 202 dependence at ARG3 and somewhat lower dependence at HIS4 (Fig 1; Fig 2B) The one outlier 203 among these ADs is the Rtg3 N-terminal AD which showed no Med15 dependence at HIS4. 204
From these results, we conclude that nearly all of these ADs function similarly to Gcn4. 205 206
Met4 contains tandem conserved ADs that overlap with ubiquitin-binding domains. 207
Based on in vivo activity, sequence conservation, and previously published work, we focused 208 further characterization on the Met4 and Ino2 ADs. sequence blocks that are conserved among closely related yeasts. Both of these conserved 211 regions are predicted to have propensity for alpha helix formation (Fig 3) . domains are contained within the region required for transcription activation and it has not 227 been determined whether these activities are overlapping or independent functions. 228 229 A series of deletions was constructed in the Met4-Gcn4 fusion to identify the minimal regions 230 necessary for AD function at ARG3, HIS4 and ILV6 (Fig 4) . As with the other chimeric activators 231 above, protein expression levels did not correlate with AD function (Fig S1) . Consistent ADs synergize at ARG3 but are approximately additive in activity at HIS4. We speculate that this 238 may be due to different coactivator dependencies at these genes. 239
240
The deletion analysis also found that Met4 residues 161-168 repress AD function 40-50%. Part 241 of this region is conserved and contains the ubiquitinated residue K163 (47, 48). Western 242 analysis is consistent with modification at this residue as this fusion protein migrates in a series 243 of slower mobility species in SDS PAGE (Fig S1) , although protein levels appear unchanged 244 compared to Met4 1-160-Gcn4. All derivatives lacking residues 161-168 show no apparent 245 modification. Mutation of K163 to R in the 1-168-Gcn4 construct eliminates both this protein 246 modification and repressive function (Fig 4; Fig S3) . Unexpectedly, blocking ubiquitination led 247 to lower levels of the fusion protein. This again shows that there is little or no correspondence 248 between protein levels and activation activity in this system. 249
250
We next examined the importance of conserved and acidic residues within each Met4 AD for 251 transcription of ARG3 and HIS4 (Fig 5) . For Met4 72-116, alanine substitution at three blocks of 252 conserved hydrophobic residues showed at least a 2-fold decrease in function at one or both of 253 the Gcn4-activated genes. In contrast, mutation of two conserved acidic residues gave no more 254 than a 40% decrease in function. Therefore, like at Gcn4, the hydrophobic residues, not the 255 acidic residues are most important for function. A similar finding was observed with the second 256 AD, Met4 131-160, where three groups of hydrophobic residues are important for function 257 while mutation of two groups of acidic residues showed no major decrease in activity. 258 259 As described above, Met4 contains tandem Ub-binding domains that overlap the two 260 conserved sequence blocks in the AD region. To test whether Ub binding and AD function are 261 separable, we tested three mutations that are known to inhibit or eliminate Ub binding (Fig 5) . 262
Within the 72-116 AD, mutations T86A and T86E, are both known to eliminate Ub binding (An 263
Tyrrell, Karin Flick, and Peter Kaiser, personal communication). These two mutants retained at 264 least 96% wild type function with no major changes in protein level (Fig S3) . Mutation A145G in 265 the context of residues 131-160, a mutation known to limit Ub binding (47), also caused no 266 decrease in AD function but did significantly reduce fusion protein levels (Fig S3) . Therefore, we 267 conclude that the Ub binding function of Met4 is not required for activator function, although 268 the two sequences overlap. 269 270 Ino2 contains tandem conserved ADs that require both hydrophobic and acidic residues for 271 function 272
Next, we examined residues important for Ino2 AD function in the Gcn4 chimeras. Ino2 and 273
Ino4 are bHLH factors required for transcriptional regulation of yeast structural genes involved 274 in phospholipid biosynthesis. Both proteins are required for sequence-specific DNA binding but 275 only Ino2 contains transcription activation function (36, 50). Previous analysis showed that, 276 when fused to the Gal4 DBD, Ino2 residues 1-35 and 98-135 have activator function and were 277 termed AD1 and AD2 (51). Mutagenesis of the AD1 showed that both hydrophobic and acidic 278 residues are required for function. AD2 overlaps with the binding site for the repressor Opi1 279 (Ino2 residues 118-135), that targets Ino2 to repress transcription in response to high levels of 280 inositol and choline (52). Mutagenesis of AD2 suggested that residues required for Opi1-281 dependent repression and AD2 function only partially overlap. 282 283 Like Met4, the Ino2 AD region contains two blocks of conserved sequence enriched for 284 hydrophobic and acidic residues of 29 and 21 residues that overlap with Ino2 AD1 and AD2 (Fig  285   3B ). Both of these conserved regions are predicted to have propensity for alpha helix 286 formation. When fused to the Gcn4 DBD and, in agreement with earlier work, we found that 287 each of the two Ino2 ADs activate ARG3 and HIS4 (Fig 6) . In our system, the minimal segments 288 necessary for AD function are Ino2 residues 1-41 and 96-160. The intervening region between 289 these two regions can be deleted with less than ˜2-fold decrease in function. Unexpectedly, we 290
found that the C-terminal AD contained a region that repressed function. Deletion of residues 291 143-150 increased activator function 2-3-fold depending on the promoter assayed (Fig 6;  292 orange rectangle). There were no obvious features in the sequence of this region that explain 293 this repressive activity. Although the Ino2 C-terminal AD is reportedly targeted by the Opi1 294 repressor (52), we found that activity of neither AD was repressed by the addition of inositol 295 and choline (not shown). This is consistent with a report that chimeric Ino2-LexA constructs 296 lacking the Ino2 DBD, are refractory to Opi1 repression (53). 297
298
To explore residues important for function of the Ino2 ADs beyond those found in previous 299 work, we mutagenized the individual ADs by double or triple substitution of Ala for 300 hydrophobic, acidic and polar residues. Function was monitored at ARG3 and HIS3 under +SM 301 inducing conditions. Residues required for the Ino2 N-terminal AD were distributed over 29 302 amino acids, almost all of which were in the conserved sequence block (Fig 7) . We found that 5 303 sets of hydrophobic mutations reduced activity ˜50% or more on at least one Gcn4-dependent 304 gene. In addition, a triple mutation of conserved acidic residues was as detrimental as most 305 mutations of hydrophobic residues. For the C-terminal AD, we found that mutations reducing 306 function were located within a 40-residue segment, much larger than the conserved sequence 307 block (Fig 7) . Ala substitutions that reduced function by at least 60% on one or both of the 308 Gcn4-dependent genes included 5 sets of hydrophobic residues and one triple mutation of 309 three conserved acidic residues. Unique to this AD, we found that mutation of conserved 310 residues S120, T121 to Ala reduced activity by at least 4-fold. Two mutations of other polar 311 residues did not affect function. In summary, residues important for both Ino2 ADs are 312 distributed over 29-40 residues and include both hydrophobic, and acidic side chains. 313 314
Met4 and Ino2 bind multiple Med15 activator binding domains 315
To explore the interactions between Med15 and the Ino2 and Met4 tandem ADs, we used 316 purified proteins in combination with isothermal titration calorimetry (ITC) and/or fluorescence 317 polarization (FP) to measure the affinities and thermodynamic properties of these interactions 318 (Figures 8-10 ; summarized in Table 1 ). Binding between the ADs and the individual Med15 319 activator binding domains was monitored using ITC. We were not able to use ITC to monitor 320 binding to the longer Med15 polypeptides (KIX +ABD1,2,3 and ABD1,2,3) so FP was employed 321 to monitor N-terminal fluorescently-labeled AD peptides binding to Med15. For comparison of 322 the two methods we used FP and ITC to monitor AD binding to ABD3 and the results were 323 similar. Met4 affinities monitored by either approach were within 20% and Ino2 affinities were 324 within ~3-fold. For the discussion below, the affinities are compared using the ITC values where 325 available. 326
327
For both ADs, we were unable to detect binding to the Med15 KIX domain. This behavior is 328 identical to that of the Gcn4 ADs (27). In contrast, both ADs bound to ABD1, 2, and 3. For Met4, 329 the order of highest to lowest binding was ABD3>ABD1>ABD2 with affinities ranging from 1 to 330 20 micromolar. The relative order of Ino2 interactions was the same, but all of the individual 331 interactions were weaker compared to Met4, ranging from 8-34 micromolar. Highest affinity 332 interactions were with Med15 polypeptides containing all ABDs: KIX + ABD1,2,3 and ABD1,2,3. 333
For both activators, constructs containing the KIX domain had the highest affinity for the ADs 334 even though binding to the isolated KIX domain was undetectable in our assays. This is 335 consistent with results found for Gcn4, where the KIX domains seemed as functionally 336 important as any of the Med15 ABDs (27) and where KIX + ABD1,2,3 had the highest affinity for 337 the tandem Gcn4 ADs (20). Combined, our results show that Med15 polypeptides with multiple 338
ABDs have much higher affinity for Met4 and Ino2. For example, Met4 binds KIX + ABD1,2,3 339 with ~7-fold higher affinity compared with ABD3 (Kd of 0.196 versus 1.36 micromolar) and Ino2 340 binds KIX + ABD1,2,3 with 36-fold higher affinity compared with ABD3 (Kd of 0.21 vs 7.8 341 micromolar). Finally, despite our finding that the Met4 had higher affinity than Ino2 for the 342 individual Med15 ABDs, the affinity of Ino2 and Met4 for the longer Med15 polypeptides was 343 remarkably similar (Kd ~0.2 micromolar for KIX + ABD1,2,3 and ~0.3 micromolar for ABD1,2,3). 344 345 Our previous work showed different thermodynamic behavior in the mechanism of Med15 346 binding to the two Gcn4 ADs (6). For example, the Gcn4 central activation domain (cAD) binding 347 to ABD1 is exothermic with a favorable change in enthalpy and a small but positive entropy 348 change. In contrast, the Gcn4 nAD binding to the individual Med15 ABD1, 2, and 3 domains are 349 endothermic, with unfavorable changes in enthalpy counteracted by large positive changes in 350 entropy. Binding of Met4 and Ino2 ADs also showed surprising and varied thermodynamic 351 behavior depending on the combination of activator and Med15 ABD (Figs 8, 10 and Table 1) . 352
For example, binding of Gcn4 nAD, Met4 AD and Ino2 AD to ABD3 is consistently endothermic. 353
In contrast, binding to ABD1 and ABD2 can be endo or exothermic depending on the activator. 354
355

Crosslinking reveals heterogeneous AD-ABD interactions within the Met4-Med15 complex 356
The individual binding measurements above showed that Met4 and Ino2 interact with both the 357 individual ABDs and longer Med15 polypeptides but these experiments cannot show whether 358 the relative affinity or ABD specificity changes in the larger complexes. For example, these 359 studies show that the KIX domain contributes to overall affinity, but does not answer whether 360 there is a direct contact between the AD and KIX. To examine the binding mechanism of the 361 Met4 tandem ADs with the full-length Med15 activator-binding regions, we used the crosslinker 362 EDC, which crosslinks acidic side chains to lysine (Fig 11; Table S2 ). EDC is a zero-length 363 crosslinker, linking only closely positioned residues and leaving no linker in the crosslinked 364 product. Analysis of the crosslinked products by mass spectrometry identified crosslinks 365 between the individual Met4 ADs and Med15 KIX, ABD1, ABD2 and ABD3. All of the 366 intermolecular crosslinks were between acidic residues in Met4 and lysine residues in Med15. found that only hydrophobic residues were critical for normal function -identical to the finding 397 of critical hydrophobic but not acidic residues in the Gcn4 ADs (18, 19, 24) . The individual Ino2 398
ADs are larger than Met4 ADs with 29 and 21 residue conserved sequence blocks. Mutagenesis 399 of the N-terminal AD found that a stretch of 29 residues was required for maximum function 400 that almost precisely coincided with the conserved sequence block. However, the C-terminal 401 AD was larger with functionally important amino acids distributed over a span of 40 residues. 402
We also found that both Ino2 ADs contained functionally important hydrophobic and acidic 403 residues. The acidic residues may function through non-specific electrostatic interactions with 404 the coactivator targets or alternatively may make direct and specific contacts. 405
406
Monitoring the binding of Ino2 and Met4 to Med15 showed that they behaved in many 407 respects like Gcn4. All bind Med15 ABD1, ABD2, and ABD3 with micromolar affinity and binding 408 to the Med15 KIX domain is undetectable in our assays. Binding of the tandem ADs to larger 409 Med15 polypeptides all have much higher affinity compared to the individual ABDs and the KIX 410 domain contributes to overall affinity under these conditions. These biochemical findings are 411 consistent with our earlier study that showed the normal in vivo response to Gcn4 activation 412 requires multiple Med15 ABDs and the KIX domain. It seems likely that, since these individual 413 binding interactions are weak, multiple binding sites are required to increase the affinity and 414 specificity into a biologically meaningful range (54, 55). This behavior is opposite from that expected because of the entropic penalty paid upon binding 420 of a disordered protein. However, it has been proposed that, even in the bound state, IDPs can 421 retain conformational entropy due to "fuzzy" protein interfaces and conformational flexibility 422 of the protein region not in direct contact with the binding partner (56). However, these 423 mechanisms do not seem to fully explain the large, positive entropy changes observed. At this 424 time, we do not understand the mechanism for the large increase in entropy upon binding, but 425 it seems to be ABD and activator-specific and is likely to at least partially result from release of 426 solvent during binding. As an example of thermodynamic specificity, binding of ABD3 to Gcn4, 427
Met4 and Ino2 is endothermic while the thermodynamics of binding to ABD1 and ABD2 is 428 activator-specific. Understanding the mechanism of endothermic binding will be important for 429 not only understanding activator mechanisms and specificity but more generally as a 430 mechanism likely used for molecular recognition by other disordered proteins. 431 17  58  56  19  56  48  30  53  50  16  53  42  10  36  30  3  10  17  10 40 36 
